Adverum Biotechnologies Inc
General ticker "ADVM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $120.8M
Adverum Biotechnologies Inc does not follow the US Stock Market performance with the rate: -22.1%.
Estimated limits based on current volatility of 3.3%: low 4.56$, high 4.87$
Short-term ADVM quotes
Long-term ADVM plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7.50MM | $0.00MM | $3.60MM |
| Operating Expenses | $153.62MM | $157.13MM | $127.39MM |
| Operating Income | $-146.12MM | $-157.13MM | $-123.79MM |
| Non-Operating Income | $0.58MM | $2.67MM | $5.55MM |
| R&D Expense | $89.18MM | $99.28MM | $77.68MM |
| Income(Loss) | $-145.54MM | $-154.46MM | $-118.24MM |
| Taxes | $0.00MM | $0.07MM | $-1.08MM |
| Profit(Loss) | $-145.54MM | $-154.54MM | $-117.17MM |
| Stockholders Equity | $316.19MM | $181.52MM | $83.47MM |
| Assets | $439.73MM | $308.37MM | $173.01MM |
| Operating Cash Flow | $-107.83MM | $-108.09MM | $-90.90MM |
| Capital expenditure | $15.12MM | $11.82MM | $0.81MM |
| Investing Cash Flow | $78.71MM | $141.72MM | $96.88MM |
| Financing Cash Flow | $2.40MM | $0.61MM | $0.07MM |
| Earnings Per Share* | $-14.85 | $-15.57 | $-11.62 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.